FHLC vs. GERM

Last updated Apr 1, 2026

Compare and contrast key facts about Fidelity MSCI Health Care Index ETF (FHLC) and Amplify Treatments, Testing and Advancements ETF (GERM).

FHLC and GERM are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FHLC is a passively managed fund by Fidelity that tracks the performance of the MSCI USA IMI Health Care Index. It was launched on Oct 21, 2013. GERM is a passively managed fund by Amplify that tracks the performance of the Prime Treatments, Testing and Advancements Index. It was launched on Jun 17, 2020. Both FHLC and GERM are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

FHLC vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity MSCI Health Care Index ETF (FHLC) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

FHLC vs. GERM - Yearly Performance Comparison

	2026 (YTD)	2025	2024
FHLC Fidelity MSCI Health Care Index ETF	-4.97%	15.42%	-9.19%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%

Returns By Period

FHLC

• 1D: 2.28%
• 1M: -7.46%
• YTD: -4.97%
• 6M: 5.95%
• 1Y: 4.53%
• 3Y*: 6.14%
• 5Y*: 5.07%
• 10Y*: 9.60%

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FHLC vs. GERM - Expense Ratio Comparison

FHLC has a 0.08% expense ratio, which is lower than GERM's 0.68% expense ratio.

GERM

Amplify Treatments, Testing and Advancements ETF

FHLC

Fidelity MSCI Health Care Index ETF

Return for Risk

FHLC vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FHLC

FHLC Risk / Return Rank: 21
FHLC Sharpe Ratio Rank: 20
FHLC Sortino Ratio Rank: 20
FHLC Omega Ratio Rank: 19
FHLC Calmar Ratio Rank: 25
FHLC Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FHLC vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FHLC	GERM	Difference
Sharpe ratio Return per unit of total volatility	0.26	—	—
Sortino ratio Return per unit of downside risk	0.48	—	—
Omega ratio Gain probability vs. loss probability	1.06	—	—
Calmar ratio Return relative to maximum drawdown	0.51	—	—
Martin ratio Return relative to average drawdown	1.08	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	FHLC	GERM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.26	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.34	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.57	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.61	—	—

Dividends

FHLC vs. GERM - Dividend Comparison

FHLC's dividend yield for the trailing twelve months is around 1.44%, while GERM has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FHLC Fidelity MSCI Health Care Index ETF	1.44%	1.40%	1.51%	1.40%	1.30%	1.16%	1.45%	1.18%	1.38%	1.38%	1.40%	2.07%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

FHLC vs. GERM - Drawdown Comparison

The maximum FHLC drawdown since its inception was -28.76%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for FHLC and GERM.

Drawdown Indicators

	FHLC	GERM	Difference
Max Drawdown Largest peak-to-trough decline	-28.76%	0.00%	-28.76%
Max Drawdown (1Y) Largest decline over 1 year	-10.38%	0.00%	-10.38%
Max Drawdown (5Y) Largest decline over 5 years	-17.73%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-28.76%	—	—
Current Drawdown Current decline from peak	-7.99%	0.00%	-7.99%
Average Drawdown Average peak-to-trough decline	-5.16%	0.00%	-5.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.04%	0.00%	+5.04%

Volatility

FHLC vs. GERM - Volatility Comparison

Fidelity MSCI Health Care Index ETF (FHLC) has a higher volatility of 5.14% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that FHLC's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FHLC	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.14%	0.00%	+5.14%
Volatility (6M) Calculated over the trailing 6-month period	10.26%	0.00%	+10.26%
Volatility (1Y) Calculated over the trailing 1-year period	17.61%	0.00%	+17.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.85%	0.00%	+14.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.82%	0.00%	+16.82%